Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Alana F. Ogata, Chi‐An Cheng, Michaël Desjardins, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 4, pp. 715-718
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Noam Barda, Noa Dagan, Cyrille J. Cohen, et al.
The Lancet (2021) Vol. 398, Iss. 10316, pp. 2093-2100
Open Access | Times Cited: 861
Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae
Zoe Swank, Yasmeen Senussi, Zachary Manickas-Hill, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e487-e490
Open Access | Times Cited: 381
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
Salma Sheikh‐Mohamed, Baweleta Isho, Gary Chao, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 5, pp. 799-808
Open Access | Times Cited: 220
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 542-554
Open Access | Times Cited: 197
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 173
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 167
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
Lael M. Yonker, Zoe Swank, Yannic C. Bartsch, et al.
Circulation (2023) Vol. 147, Iss. 11, pp. 867-876
Open Access | Times Cited: 149
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 126
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano, Disha Bhavsar, Gagandeep Singh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 119
The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling
Juan Pablo Robles, Magdalena Zamora, Elva Adán‐Castro, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101695-101695
Open Access | Times Cited: 116
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 81
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 77
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis
Nicolas Hulscher, Roger Hodkinson, William Makis, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 29
Myocarditis associated with COVID-19 vaccination
Alessandra Buoninfante, Arno C. Andeweg, Georgy Genov, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae
Zoe Swank, Yasmeen Senussi, Galit Alter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 62
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 62
The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin
Cynthia M. Magro, A. Neil Crowson, Linda Franks, et al.
Clinics in Dermatology (2021) Vol. 39, Iss. 6, pp. 966-984
Open Access | Times Cited: 57
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
Tudor Emanuel Fertig, Leona Chiţoiu, Daciana Marta, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1538-1538
Open Access | Times Cited: 52
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy
Mary Prahl, Yarden Golan, Arianna G. Cassidy, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 49
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection*
Salma Sheikh‐Mohamed, Erin C. Sanders, Jennifer L. Gommerman, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 75-85
Open Access | Times Cited: 46
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Marco Cosentino, Franca Marino
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10881-10881
Open Access | Times Cited: 41
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
Dimitra S. Mouliou, Efthimios Dardiotis
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1555-1555
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top